End-Stage Kidney Disease

SAN DIEGO — Blood volume monitoring may lead to shorter hospital stays and fewer readmissions for adults with end-stage kidney disease and heart failure, data show.

For some patients, home therapies are preferable to in-center dialysis treatment. This option has been associated with improved patient outcomes and increased overall quality of life for many patients with end-stage kidney disease.

There may be a nonlinear connection between platelet count and 30-day in-hospital mortality in patients with end-stage kidney disease in the ICU, according to researchers.

An early diagnosis of antibody-associated vasculitis may be important to long-term kidney function, study data show, as even mild forms of kidney involvement can affect prognosis.

A biotechnology company developing compatible organs for transplantation to humans, eGenesis, secured financial backing that could eventually lead to a human trial of its bioengineered pig kidney, according to a company press release.

Chronic kidney disease-associated pruritus may often be insufficiently treated and can disrupt dialysis treatment for patients who report itch to health care providers.

Rate of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease varies between European countries and was highest for immunoglobulin A nephropathy and focal segmental glomerulosclerosis, study data show.

A bipartisan bill introduced in the U.S. Senate would require private health plans to continue to pay for dialysis for beneficiaries with end-stage kidney disease while they coordinate a transition to Medicare coverage.

During a 20-year period, patients with end-stage kidney disease treated with hemodialysis saw a reduction in mortality worldwide, study results show. The biggest gain in survival was among patients the United States.

A topical cream containing cannabis “significantly reduced the severity of itching” symptoms in patients with chronic kidney disease-related pruritus, according to published data.